<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title>Submission to The Science and Technology Committee inquiry into the aftermath of the closure of the FSS from Promega UK Ltd</title></head><body><div><p style="background-color:#ffffff; line-height:15.6pt; margin:0pt; text-align:center"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Written evidence submitted by Promega UK Ltd (FSS042)</span></p><p style="background-color:#ffffff; line-height:15.6pt; margin:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="background-color:#ffffff; line-height:15.6pt; margin:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Does the Government have an effective strategy for forensic science in the UK and is it sufficient to support forensic science R&amp;D and criminal justice?</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol type="1" style="margin:0pt; padding-left:0pt"><ol type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Historically, the UK has led the world in the application of DNA t</span><span style="font-family:'Times New Roman'; font-size:11pt">echnology to forensic science. </span><span style="font-family:'Times New Roman'; font-size:11pt">The first cases were analysed over 2</span><span style="font-family:'Times New Roman'; font-size:11pt">5 years ago by </span><span style="font-family:'Times New Roman'; font-size:11pt">pioneers </span><span style="font-family:'Times New Roman'; font-size:11pt">Sir Alec Jeffreys</span><span style="font-family:'Times New Roman'; font-size:11pt">, Peter </span><span style="font-family:'Times New Roman'; font-size:11pt">Gill and</span><span style="font-family:'Times New Roman'; font-size:11pt"> Dav</span><span style="font-family:'Times New Roman'; font-size:11pt">e</span><span style="font-family:'Times New Roman'; font-size:11pt"> Werre</span><span style="font-family:'Times New Roman'; font-size:11pt">t</span><span style="font-family:'Times New Roman'; font-size:11pt">t using multilocus probes. Later, single locus probes were used by Cell</span><span style="font-family:'Times New Roman'; font-size:11pt">ma</span><span style="font-family:'Times New Roman'; font-size:11pt">rk and the</span><span style="font-family:'Times New Roman'; font-size:11pt"> Forensic Science Service</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">for paternity and </span><span style="font-family:'Times New Roman'; font-size:11pt">c</span><span style="font-family:'Times New Roman'; font-size:11pt">riminal casework </span><span style="font-family:'Times New Roman'; font-size:11pt">analyses </span><span style="font-family:'Times New Roman'; font-size:11pt">respectively.  The development of short tandem repeat (STR) technology, first implemented in the UK in 1994 allowed the idea of a simple to use DNA database to be conceptualised, and the development of a second generation multiplex (SGM) system for the simultaneous analysis of 6 STRs allowed the establishment of t</span><span style="font-family:'Times New Roman'; font-size:11pt">he world’s first DNA database. </span><span style="font-family:'Times New Roman'; font-size:11pt">A new chemistry (SGM Plus) was </span><span style="font-family:'Times New Roman'; font-size:11pt">introduced </span><span style="font-family:'Times New Roman'; font-size:11pt">to the National DNA Database (NDNAD) </span><span style="font-family:'Times New Roman'; font-size:11pt">in</span><span style="font-family:'Times New Roman'; font-size:11pt"> 1999 to include </span><span style="font-family:'Times New Roman'; font-size:11pt">4 </span><span style="font-family:'Times New Roman'; font-size:11pt">additional STRs providing improved match statistics</span><span style="font-family:'Times New Roman'; font-size:11pt">, and better performance in terms of sensitivity</span><span style="font-family:'Times New Roman'; font-size:11pt">. </span><span style="font-family:'Times New Roman'; font-size:11pt">The power of the NDNAD is of great value in forensic investigation. </span><span style="font-family:'Times New Roman'; font-size:11pt">Since 1998, more than 300,000 crimes have been detected with the aid of the Database, </span><a name="_GoBack"></a><span style="font-family:'Times New Roman'; font-size:11pt">reassuring the public that offenders are more likely to be brought to justice.  Indeed,  between 01 April 2012 and 30 September 2012 the NDNAD produced 61 matches to murder, 225 to rapes and 12,537 to other crime scenes [1]</span></li></ol></ol><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="2" type="1" style="margin:0pt; padding-left:0pt"><ol start="2" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">In 2006, the European Network of Forensic Science Institutes</span><span style="font-family:'Times New Roman'; font-size:11pt"> (ENFSI)</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">suggested that additional loci and more robust DNA chemistries would be required for forensic science, particularly with the proposed exchange of DNA data in accordance with the Prϋm treaty</span><span style="font-family:'Times New Roman'; font-size:11pt"> [2</span><span style="font-family:'Times New Roman'; font-size:11pt">, 3</span><span style="font-family:'Times New Roman'; font-size:11pt">]</span><span style="font-family:'Times New Roman'; font-size:11pt">.  This requirement for improved DNA systems was </span><span style="font-family:'Times New Roman'; font-size:11pt">made </span><span style="font-family:'Times New Roman'; font-size:11pt">a European Council Resolution</span><span style="font-family:'Times New Roman'; font-size:11pt"> in 2009 </span><span style="font-family:'Times New Roman'; font-size:11pt">[</span><span style="font-family:'Times New Roman'; font-size:11pt">4</span><span style="font-family:'Times New Roman'; font-size:11pt">]</span><span style="font-family:'Times New Roman'; font-size:11pt"> with a requirement for member countries to implement the new chemistries</span><span style="font-family:'Times New Roman'; font-size:11pt"> as soon as practically possible, and </span><span style="font-family:'Times New Roman'; font-size:11pt">no later than </span><span style="font-family:'Times New Roman'; font-size:11pt">November</span><span style="font-family:'Times New Roman'; font-size:11pt"> 30 </span><span style="font-family:'Times New Roman'; font-size:11pt">2012.  </span><span style="font-family:'Times New Roman'; font-size:11pt">NPIA </span><span style="font-family:'Times New Roman'; font-size:11pt">were fully</span><span style="font-family:'Times New Roman'; font-size:11pt"> aware</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">of these timelines as they have representation at the ENFSI DNA meetings</span><span style="font-family:'Times New Roman'; font-size:11pt">, and access to publicly available publications</span><span style="font-family:'Times New Roman'; font-size:11pt">.  </span></li></ol></ol><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="3" type="1" style="margin:0pt; padding-left:0pt"><ol start="3" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The development of new chemistries by leading manufacturers including Promega, Life Technologies and Qiagen has provided an opportunity to not only include additional loci as per the ENFSI requirement, but also to improve the robustness of the chemistries.  The new chemistries </span><span style="font-family:'Times New Roman'; font-size:11pt">(let’s call </span><span style="font-family:'Times New Roman'; font-size:11pt">them </span><span style="font-family:'Times New Roman'; font-size:11pt">Next Generation </span><span style="font-family:'Times New Roman'; font-size:11pt">Chemistries </span><span style="font-family:'Times New Roman'; font-size:11pt">(NGC)) </span><span style="font-family:'Times New Roman'; font-size:11pt">from each of these commercial </span><span style="font-family:'Times New Roman'; font-size:11pt">suppliers are</span><span style="font-family:'Times New Roman'; font-size:11pt"> much more robust to inhibitors, have more “miniSTR” markers and are more sensitive, suggesting that meaningful results </span><span style="font-family:'Times New Roman'; font-size:11pt">are more </span><span style="font-family:'Times New Roman'; font-size:11pt">likely</span><span style="font-family:'Times New Roman'; font-size:11pt"> to</span><span style="font-family:'Times New Roman'; font-size:11pt"> be obtained from more challenging samples with new chemistries than the </span><span style="font-family:'Times New Roman'; font-size:11pt">only chemistry that is </span><span style="font-family:'Times New Roman'; font-size:11pt">currently </span><span style="font-family:'Times New Roman'; font-size:11pt">approved for use on the database </span><span style="font-family:'Times New Roman'; font-size:11pt">SGM </span><span style="font-family:'Times New Roman'; font-size:11pt">Plus. </span><span style="font-family:'Times New Roman'; font-size:11pt">The</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">NGC chemistries developed by </span><span style="font-family:'Times New Roman'; font-size:11pt">Promega (</span><span style="font-family:'Times New Roman'; font-size:11pt">PowerPlex ESI / ESX) have been fully commercially available since 2009.</span></li></ol></ol><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="4" type="1" style="margin:0pt; padding-left:0pt"><ol start="4" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">C</span><span style="font-family:'Times New Roman'; font-size:11pt">ompetition in the marketplace is likely to drive innovation and improvement of DNA analysis reagents which will be of benefit to the criminal justice system. Indeed, the </span><span style="font-family:'Times New Roman'; font-size:11pt">NGC </span><span style="font-family:'Times New Roman'; font-size:11pt">chemistries developed by Promega in response to the European requirement</span><span style="font-family:'Times New Roman'; font-size:11pt"> PowerPlex ESI / ESX</span><span style="font-family:'Times New Roman'; font-size:11pt"> have</span><span style="font-family:'Times New Roman'; font-size:11pt"> already</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">been superseded on 2 occasions to date, with the implementation of direct amplification and faster amplification (PowerPlex 18D),</span><span style="font-family:'Times New Roman'; font-size:11pt"> and further</span><span style="font-family:'Times New Roman'; font-size:11pt"> robust</span><span style="font-family:'Times New Roman'; font-size:11pt">ness in</span><span style="font-family:'Times New Roman'; font-size:11pt"> amplification (PowerPlex 21; PowerPlex Fusion).</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">Promega’s next</span><span style="font-family:'Times New Roman'; font-size:11pt"> generation (3 generations on from NGC, 4 from SGM Plus) will be available in April 2013 and will include all existing improvements, </span><span style="font-family:'Times New Roman'; font-size:11pt">as well as </span><span style="font-family:'Times New Roman'; font-size:11pt">the ability to rapidly cycle, reducing the amplification time from 1.5 hours to 45 minutes. </span></li></ol></ol><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="5" type="1" style="margin:0pt; padding-left:0pt"><ol start="5" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Through red tape, and/or a lack of </span><span style="font-family:'Times New Roman'; font-size:11pt">strategic planning or </span><span style="font-family:'Times New Roman'; font-size:11pt">deci</span><span style="font-family:'Times New Roman'; font-size:11pt">sion making and poor resource management</span><span style="font-family:'Times New Roman'; font-size:11pt"> causing delays to</span><span style="font-family:'Times New Roman'; font-size:11pt"> planning and</span><span style="font-family:'Times New Roman'; font-size:11pt"> implementation, the UK is now one of the very few European countries who have not implemented modern</span><span style="font-family:'Times New Roman'; font-size:11pt"> robust </span><span style="font-family:'Times New Roman'; font-size:11pt">chemistries.</span><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span><span style="font-family:'Times New Roman'; font-size:11pt"> Whilst the new European NGC systems have been evaluated by a number</span><span style="font-family:'Times New Roman'; font-size:11pt"> of</span><span style="font-family:'Times New Roman'; font-size:11pt"> UK forensic science providers, and findings published [5-7], implementation of the improved systems is not yet possible as the results cannot currently be loaded to the NDNAD.</span></li></ol></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 36pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="6" type="1" style="margin:0pt; padding-left:0pt"><ol start="6" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">In an attempt to put the UK </span><span style="font-family:'Times New Roman'; font-size:11pt">forensic DNA </span><span style="font-family:'Times New Roman'; font-size:11pt">marketplace into perspective</span><span style="font-family:'Times New Roman'; font-size:11pt">:</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">m</span><span style="font-family:'Times New Roman'; font-size:11pt">ost of Europe are already using the “next generation chemistries”, including</span><span style="font-family:'Times New Roman'; font-size:11pt">:</span></li></ol><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Sweden – </span><span style="font-family:'Times New Roman'; font-size:11pt">PowerPlex </span><span style="font-family:'Times New Roman'; font-size:11pt">ESX16; </span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Norway – </span><span style="font-family:'Times New Roman'; font-size:11pt">PowerPlex </span><span style="font-family:'Times New Roman'; font-size:11pt">ESI17; </span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Estonia – </span><span style="font-family:'Times New Roman'; font-size:11pt">PowerPlex </span><span style="font-family:'Times New Roman'; font-size:11pt">ESI16; </span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Finland – ESSplex Plus;</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Denmark – NGM SElect; </span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Ireland – NGM SElect; </span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Belgium – </span><span style="font-family:'Times New Roman'; font-size:11pt">PowerPlex </span><span style="font-family:'Times New Roman'; font-size:11pt">ESX</span><span style="font-family:'Times New Roman'; font-size:11pt">16/</span><span style="font-family:'Times New Roman'; font-size:11pt">17; </span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Germany – </span><span style="font-family:'Times New Roman'; font-size:11pt">PowerPlex </span><span style="font-family:'Times New Roman'; font-size:11pt">ESI/X17; </span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Poland – </span><span style="font-family:'Times New Roman'; font-size:11pt">PowerPlex </span><span style="font-family:'Times New Roman'; font-size:11pt">ESX16/NGM; </span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Italy –</span><span style="font-family:'Times New Roman'; font-size:11pt"> PowerPlex</span><span style="font-family:'Times New Roman'; font-size:11pt"> ESI/X16/ESSplex; </span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Luxemburg – </span><span style="font-family:'Times New Roman'; font-size:11pt">PowerPlex </span><span style="font-family:'Times New Roman'; font-size:11pt">ESI</span><span style="font-family:'Times New Roman'; font-size:11pt">/X16; </span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Switzerland – PowerPlex ESI17</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Czech Republic </span><span style="font-family:'Times New Roman'; font-size:11pt">–</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">ESI/X17</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Slovakia – PowerPlex ESI17</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Poland – PowerPlex ESI/X17</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Hungary – PowerPlex ESI16</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Russia – PowerPlex ESX17</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Greece and Cyprus – ESX17</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Turkey – PowerPlex ESX16/ESSplex</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Israel – PowerPlex ESI16</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 84.21pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Algeria – PowerPlex ESI16 </span></li></ul></ol><p style="margin:0pt 0pt 0pt 70.9pt"><span style="font-family:'Times New Roman'; font-size:11pt">NOTE: This list is not intended to be definitive and other chemistries may also be in use in these countries</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span></p><p style="margin:0pt 0pt 0pt 70.9pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 70.9pt"><span style="font-family:'Times New Roman'; font-size:11pt">France </span><span style="font-family:'Times New Roman'; font-size:11pt">is</span><span style="font-family:'Times New Roman'; font-size:11pt"> currently using </span><span style="font-family:'Times New Roman'; font-size:11pt">PowerPlex </span><span style="font-family:'Times New Roman'; font-size:11pt">18D for database samples and </span><span style="font-family:'Times New Roman'; font-size:11pt">PowerPlex </span><span style="font-family:'Times New Roman'; font-size:11pt">21 for casework.  Spain will be implementing</span><span style="font-family:'Times New Roman'; font-size:11pt"> PowerPlex</span><span style="font-family:'Times New Roman'; font-size:11pt"> Fusion in the near future for casework and database samples. Belgium is already using </span><span style="font-family:'Times New Roman'; font-size:11pt">European </span><span style="font-family:'Times New Roman'; font-size:11pt">NGC </span><span style="font-family:'Times New Roman'; font-size:11pt">STR</span><span style="font-family:'Times New Roman'; font-size:11pt"> systems and are considering moving to a global kit</span><span style="font-family:'Times New Roman'; font-size:11pt"> (such as PowerPlex Fusion or GlobaFiler)</span><span style="font-family:'Times New Roman'; font-size:11pt"> in the near future. </span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="7" type="1" style="margin:0pt; padding-left:0pt"><ol start="7" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">It seems that the UK has moved position from “Pioneer” to “nowhere near” through the inability of the NPIA, and specifically the National DNA database to respond to changes in the forensic DNA marketplace and legislative requirements, despite having known that there were changes coming from as early as 2006.  The UK is currently using </span><span style="font-family:'Times New Roman'; font-size:11pt">13 year </span><span style="font-family:'Times New Roman'; font-size:11pt">old STR chemistry and paying over the odds for the privilege, both in terms of pricing owing to </span><span style="font-family:'Times New Roman'; font-size:11pt">a </span><span style="font-family:'Times New Roman'; font-size:11pt">single supplier</span><span style="font-family:'Times New Roman'; font-size:11pt"> monopoly</span><span style="font-family:'Times New Roman'; font-size:11pt">, and in success rates of crime sample DNA analysis. </span><span style="font-family:'Times New Roman'; font-size:11pt">This constitutes a potential quality issue. Crime samples of low quality which will give poor or no results with the current chemistry</span><span style="font-family:'Times New Roman'; font-size:11pt"> have a high probability of giving more information or full profiles</span><span style="font-family:'Times New Roman'; font-size:11pt">, with NGC or newer chemistries</span><span style="font-family:'Times New Roman'; font-size:11pt"> [</span><span style="font-family:'Times New Roman'; font-size:11pt">6-</span><span style="font-family:'Times New Roman'; font-size:11pt">8]</span><span style="font-family:'Times New Roman'; font-size:11pt">.  It is conceivable that such additional DNA information might prove the difference between solving a crime or not.</span></li></ol></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 36pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="8" type="1" style="margin:0pt; padding-left:0pt"><ol start="8" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 67.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">In summary, the NPIA have been unable to respond to the</span><span style="font-family:'Times New Roman'; font-size:11pt"> requirements of the</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">forensic </span><span style="font-family:'Times New Roman'; font-size:11pt">market place</span><span style="font-family:'Times New Roman'; font-size:11pt">, or to European Union Council Resolution</span><span style="font-family:'Times New Roman'; font-size:11pt">.  There is a desire and a moral obligation for a forensic scientist to apply the best tools possible</span><span style="font-family:'Times New Roman'; font-size:11pt"> to his/her investigation. In the case of DNA analysis, the forensic community </span><span style="font-family:'Times New Roman'; font-size:11pt">in the UK </span><span style="font-family:'Times New Roman'; font-size:11pt">are currently being prevented from applying modern, robust chemistries which in some cases would provide information where the current system would provide little or no data.  The strategy and work flow for upgrading the database to allow </span><span style="font-family:'Times New Roman'; font-size:11pt">the use of new STR </span><span style="font-family:'Times New Roman'; font-size:11pt">chemistries has put the UK at least 2 years behind the rest of Europe, in terms of DNA analysis</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> in the forensic field.</span></li></ol></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 36pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Declaration of interests:</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:11pt">The Authors are employed by Promega UK, a supplier of reagents to the forensic community and a competitor to Life Technologies, the current sole supplier of STR Chemistry loadable to the National DNA Database.  </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:11pt">References</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:11pt"> [1]  </span><span style="font-family:'Times New Roman'; font-size:11pt">http://www.npia.police.uk/en/8934.htm</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt"> Accessed 3rd Jan 2013</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">[2] P. Gill, L. Fereday, N. Morling, P.M. Schneider, The evolution of DNA databases – recommendations for new European STR loci, Forensic Sci. Int. 156 (2006) 242– 244.</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">[3] P. Gill, L. Fereday, N. Morling, P.M. Schneider, New multiplexes for Europe – amendments and clarification of strategic development, Forensic Sci. Int. 163 (2006) 155–157.</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:11pt">[4] Council resolution of 30</span><span style="font-family:'Times New Roman'; font-size:7.33pt; vertical-align:super">th</span><span style="font-family:'Times New Roman'; font-size:11pt"> November 2009 on the exchange of DNA analysis results. Official Journal of the European Union 5.11.2009  (2009/C 296/01) </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:11pt">[5]  V.C. Tucker, et al., UK population data generated with the PowerPlex® ESI 16 system, Forensic Sci. Int. Genet. (2011), doi:10.1016/j.fsigen.2011.08.005</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:11pt">[6] S. Kutranov Comparison study of four different 16-locus ''expanded ESS'' STR kits Forensic Science International Genetics Supplemental Series  3(1):0 (2011)</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:11pt">[7] V.C. Tucker et al., Forensic Validation of the PowerPlex® </span><span style="font-family:'Times New Roman'; font-size:11pt">ESI</span><span style="font-family:'Times New Roman'; font-size:11pt"> 16 </span><span style="font-family:'Times New Roman'; font-size:11pt">STR</span><span style="font-family:'Times New Roman'; font-size:11pt"> multiplex and comparison of performance with Amp</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Fl</span><span style="font-family:'Times New Roman'; font-size:11pt">STR® SGM Plus </span><a href="http://rd.springer.com/journal/414"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; text-decoration:none">International Journal of Legal Medicine</span></a><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">&#xa0;</span><br /><a href="http://rd.springer.com/journal/414/126/3/page/1"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; text-decoration:none">126, (3) 345-356</span></a></p><p style="margin:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; text-decoration:none">[8] </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; text-decoration:none">J. Hedman et al.,</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; text-decoration:none">Evaluation of three new forensic DNA profiling kits on PCR-inhibitory crime</span></p><p style="margin:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; text-decoration:none">scene samples</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; text-decoration:none">, Forensic</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; text-decoration:none"> Science International: Genetics Supplement Series 3 (2011) e457–e458</span></p><p style="margin:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic; text-decoration:none">January 2013</span></p></div></body></html>